Produkty 51-77-4

CAS 51-77-4 występuje w naszej ofercie pod nazwami: Gefarnate, 95%, Gefarnate (Mixture of Isomers), Gefarnate/ 97.1% (existing batch purity), Gefarnate, Gefarnate, 98.0%. Oferty producentów: Combi-blocks, TRC, TargetMol, GLPBio, Biosynth. Dostępne opakowania: 1g, 250mg, 2,5g, 500mg, 100mg, 200mg, 10mM (in 1ml dmso), 50mg.

Gefarnate, 95%
Combi-blocks
  • opakowanie: 1g, 250mg
  • Warianty: 2
Zobacz produkt
Gefarnate (Mixture of Isomers)
TRC
  • opakowanie: 2,5g, 250mg, 500mg
  • Warianty: 3
Zobacz produkt
Gefarnate/ 97.1% (existing batch purity)
TargetMol
  • opakowanie: 100mg, 200mg
  • Warianty: 2
od 439,25
Zobacz produkt
Gefarnate
GLPBio, Biosynth, Chemat
  • opakowanie: 100mg, 10mM (in 1ml dmso), 50mg, 250mg
  • Warianty: 12
od 170,00
Zobacz produkt
Gefarnate, 98.0%
MedChemExpress
  • opakowanie: 100 mg, 50 mg, 10mM/1mL
  • Warianty: 3
od 361,49
Zobacz produkt
GEFARNATE, >=95%
Fluorochem
  • opakowanie: 1g
  • Warianty: 1
od 3855,95
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate (CAS 51-77-4) to związek chemiczny o wzorze sumarycznym C27H44O2 i masie molowej 400.6 g/mol. Nazwa systematyczna IUPAC: [(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate. InChIKey: ZPACYDRSPFRDHO-ROBAGEODSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O2
Masa molowa400.6 g/mol
Nazwa IUPAC[(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate
InChIKeyZPACYDRSPFRDHO-ROBAGEODSA-N
SMILESCC(=CCC/C(=C/CC/C(=C/CCC(=O)OC/C=C(\C)/CCC=C(C)C)/C)/C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: gefarnate, Geranyl farnesylacetate, Gefarnato, Gefanil, Gefarnatum, trans-3,7-Dimethyl-2,6-octadienyl 5,9,13-trimethyl-4,8,12-tetradecatrienoate, Farnesylacetate, Geranyl, Gefarnyl, 3,7-dimethylocta-2,6-dien-1-yl 5,9,13-trimethyltetradeca-4,8,12-trienoate, Gefarnate (Mixture of Isomers)
Izomery (ten sam wzór sumaryczny)
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O2
(1S)-3-[(Z)-2-[(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O2
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-7,7,7-trideuterio-6-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-4-[(2S)-3,3-dimethyloxiran-2-yl]butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O2
(1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O2
(8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C27H44O2
(3S,9R,10S,13R,14R,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O2
(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-7-one C27H44O2
trans-(1R,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O2
(6R)-6-[(3S,10R,13R,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-one C27H44O2
cis-(1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C27H44O2